SCHEMBL17009398

SCHEMBL17009398

COC(=O)C1CC(F)(F)CCN1C(C)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNQ3 O43525 2/20 0.42
KCNQ2 O43526 2/20 0.42
KCNQ4 P56696 1/20 0.42
KCNQ5 Q9NR82 1/20 0.42
CYP3A4 P08684 6/20 0.42
CYP1A2 P05177 5/20 0.42
TSHR P16473 3/20 0.42
HSD17B10 Q99714 2/20 0.42
CYP2D6 P10635 2/20 0.42
MAPK1 P28482 1/20 0.42
CYP2C19 P33261 4/20 0.41
ALDH1A1 P00352 5/20 0.40
KDM4E B2RXH2 1/20 0.40
ATM Q13315 1/20 0.40
CYP2C9 P11712 4/20 0.40
LMNA P02545 2/20 0.40
OPRM1 P35372 1/20 0.40
OPRK1 P41145 1/20 0.40
OPRL1 P41146 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16282516 1.00 KCNQ3 (0.42) KCNQ3KCNQ2KCNQ4KCNQ5CYP3A4
SCHEMBL16277270 1.00 KCNQ3 (0.42) KCNQ3KCNQ2KCNQ4KCNQ5CYP3A4
SCHEMBL2772366 0.81 TSHR (0.44) CYP3A4CYP1A2TSHRHSD17B10CYP2D6
SCHEMBL7064464 0.81 TSHR (0.44) CYP3A4CYP1A2TSHRHSD17B10CYP2D6
SCHEMBL7060888 0.81 TSHR (0.44) CYP3A4CYP1A2TSHRHSD17B10CYP2D6
SCHEMBL2773433 0.81 TSHR (0.44) CYP3A4CYP1A2TSHRHSD17B10CYP2D6
SCHEMBL2772125 0.81 TSHR (0.44) CYP3A4CYP1A2TSHRHSD17B10CYP2D6
SCHEMBL2770246 0.79 TSHR (0.52) CYP3A4CYP1A2TSHRHSD17B10CYP2D6
SCHEMBL2774395 0.79 TSHR (0.52) CYP3A4CYP1A2TSHRHSD17B10CYP2D6
SCHEMBL7971333 0.79 TSHR (0.52) CYP3A4CYP1A2TSHRHSD17B10CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015123355-A1 SUBSTITUTED PROLINES / PIPERIDINES AS OREXIN RECEPTOR ANTAGONISTS EOLAS THERAPEUTICS, INC. (US) 2015-08-20 WO disclosed